8-K
Current Report
Damora Therapeutics, Inc. Filed Acc 0000950170-23-028265
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading glto-20230614.htm…